Tissue Regenix Group plc
Company Profile
Company website
Sector
Pharmaceuticals & Biotechnology (Biotechnology)
Description
Tissue Regenix Group plc (AIM: TRX) is a pioneering, international medical technology company focused on the development of regenerative products using two platform technologies, dCELL®, addressing soft tissue needs, and BioRinse™, providing inductive bone allografts.
Investor Access
07
Sep
Event information
Management will hold a presentation for Investors through the digital platform, Investor Meet Company, on Wednesday 7th September 2022 at 4.30pm relating to its interim results. Investors can sign up to Investor Meet Company for free, by clicking here
Venue
Online
Time
7th September 2022 at 4:30PM
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | June |
| Interim Results* | 7 September |
| AGM* | June |
* Months based on previous announcements of this kind
